EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1
EU-IMPLANTABLE_MEDICAL_DEVICES-ART_3_ANX_1
Active Implantable Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 90/385/EEC on Active Implantable Medical Devices, 20 July 1990, amended by Directive 2007/47/EC, 21 September 2007
This list contains hazardous substances for purposes of Directive 90/385/EEC on active implantable medical devices, particularly as regards Article 3 and Annex I (Essential Requirements). This non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Please note that Regulation (EU) 2017/745 on medical devices has repealed Directive 90/385/EEC and begun to apply from 26 May 2021. Nevertheless, Article 120 of the Regulation provides for a transitional period allowing medical devices, under specified conditions (e.g., placed on the market prior to 26 May 2021), to continue to comply with the Directive. In accordance with the fourth paragraph of Article 120, this period ends 26 May 2025.
Last updated 26 April 2024. Database contains 4753 unique substances/entries.
Filter the list
|
-
|
-
|
P Parasites |
|||
|
600-662-6
|
105512-06-9
|
Acute Tox. 4; STOT RE 2; Skin Sens. 1 |
|||
|
619-396-7
|
99129-21-2
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350°C (662°F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.
|
269-782-0
|
68333-26-6
|
Carc. 1B |
||
|
A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350°C (662°F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.
|
265-064-6
|
64741-62-4
|
Carc. 1B |
||
|
-
|
-
|
F Fungi |
|||
|
245-119-0
|
22605-92-1
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
242-161-1
|
18283-82-4
|
Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
226-394-6
|
5392-40-5
|
Skin Irrit. 2; Skin Sens. 1 |
|||
|
205-859-7
|
156-59-2
|
Flam. Liq. 2; Acute Tox. 4 |
|||
|
236-086-3
|
13149-00-3
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
231-187-9
|
7443-70-1
|
Acute Tox. 4 |
|||
|
422-660-2
|
7480-35-5
|
Eye Dam. 1; Skin Sens. 1 |
|||
|
PD 133602-2
|
417-430-3
|
63645-17-0
|
Acute Tox. 3; STOT RE 2; Skin Sens. 1 |
||
|
426-020-3
|
51229-78-8
|
Flam. Sol. 2; Repr. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1 |
|||
|
425-080-8
|
104860-26-6
|
Acute Tox. 4; STOT RE 2; Eye Dam. 1 |
|||
|
213-308-7
|
935-79-5
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
216-906-6
|
1694-82-2
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
ARGOLD; CINMETHYLIN; WL 95481
|
402-410-9
|
87818-31-3
|
Acute Tox. 4 |
||
|
604-318-6
|
142891-20-1
|
Carc. 2; Skin Sens. 1 |
|||
|
204-454-2
|
121-20-0
|
Acute Tox. 4 |
|||
|
246-948-0
|
25402-06-6
|
Acute Tox. 4 |
|||
|
232-671-2
|
9004-07-3
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1 |
|||
|
207-803-7
|
495-54-5
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2 |
|||
|
264-409-8
|
63681-54-9
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
282-432-1
|
84196-22-5
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
208-545-8
|
532-82-1
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
278-290-5
|
75660-25-2
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
281-549-5
|
83968-67-6
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
304-236-8
|
94247-67-3
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
286-946-7
|
85407-90-5
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
279-116-0
|
79234-33-6
|
Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1 |
|||
|
205-923-4
|
218-01-9
|
Carc. 1B; Muta. 2 |
yes |
||
|
239-056-8
|
14977-61-8
|
Ox. Liq. 1; Carc. 1B; Muta. 1B; Skin Corr. 1A; Skin Sens. 1 |
|||
|
215-607-8
|
1333-82-0
|
Ox. Sol. 1; Carc. 1A; Muta. 1B; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Skin Corr. 1A; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
-
|
-
|
Carc. 1B; Skin Sens. 1 |
|||
|
231-801-5
|
7738-94-5
|
yes |
|||
|
282-714-4
|
84332-86-5
|
Carc. 2 |
|||
|
244-663-6
|
21923-23-9
|
Acute Tox. 2; Acute Tox. 3 |
|||
|
207-902-5
|
500-28-7
|
Acute Tox. 4 |
|||
|
217-637-7
|
1918-13-4
|
Acute Tox. 4 |
|||
|
227-011-5
|
5598-13-0
|
Skin Sens. 1 |
|||
|
220-864-4
|
2921-88-2
|
Acute Tox. 3 |
|||
|
202-925-7
|
101-21-3
|
Carc. 2; STOT RE 2 |
|||
|
204-105-4
|
115-78-6
|
Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
215-316-6
|
1321-23-9
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
221-437-5
|
3091-32-5
|
Acute Tox. 4 |
|||
|
239-592-2
|
15545-48-9
|
Carc. 2; Repr. 2 |
|||
|
246-698-2
|
25168-05-2
|
Acute Tox. 4 |
|||
|
217-588-1
|
1897-45-6
|
Carc. 2; Acute Tox. 2; STOT SE 3; Eye Dam. 1; Skin Sens. 1 |
|||